ATE150462T1 - Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung - Google Patents

Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung

Info

Publication number: ATE150462T1
Authority: AT; Austria
Prior art keywords: production; pyrazolopyridine compounds; pharmaceutically acceptable; pyrazolopyridine; compounds
Prior art date: 1989-01-23

Application number

AT90101042T

Other languages

English (en)

Inventor

Youichi Shiokawa

Atsushi Akahane

Hirohito Katayama

Takafumi Mitsunaga

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-23

Filing date

1990-01-19

Publication date

1997-04-15

1990-01-19 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1997-04-15 Application granted granted Critical

1997-04-15 Publication of ATE150462T1 publication Critical patent/ATE150462T1/de

Links

150000005229 pyrazolopyridines Chemical class 0.000 title 1
125000003118 aryl group Chemical group 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
-1 pyrazolopyridine compound Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

AT90101042T 1989-01-23 1990-01-19 Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung ATE150462T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898901423A GB8901423D0 (en)	1989-01-23	1989-01-23	Pyrazolopyridine compound and processes for preparation thereof

Publications (1)

Publication Number	Publication Date
ATE150462T1 true ATE150462T1 (de)	1997-04-15

Family

ID=10650453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90101042T ATE150462T1 (de)	1989-01-23	1990-01-19	Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung

Country Status (23)

Country	Link
US (1)	US4985444A (de)
EP (1)	EP0379979B1 (de)
JP (2)	JPH0794454B2 (de)
KR (1)	KR0159502B1 (de)
CN (1)	CN1031570C (de)
AT (1)	ATE150462T1 (de)
AU (1)	AU628913B2 (de)
CA (1)	CA2008263C (de)
DE (1)	DE69030206T2 (de)
DK (1)	DK0379979T3 (de)
ES (1)	ES2098229T3 (de)
FI (1)	FI96205C (de)
GB (1)	GB8901423D0 (de)
GR (1)	GR3023219T3 (de)
HU (2)	HUT53368A (de)
IE (1)	IE900161L (de)
IL (1)	IL93050A (de)
NO (1)	NO176356C (de)
PH (1)	PH30968A (de)
PT (1)	PT92935B (de)
RU (1)	RU2007403C1 (de)
UA (1)	UA43821C2 (de)
ZA (1)	ZA90200B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5155114A (en) *	1989-01-23	1992-10-13	Fujisawa Pharmaceutical Company, Ltd.	Method of treatment using pyrazolopyridine compound
US5338743A (en) *	1988-06-06	1994-08-16	Fujisawa Pharmaceutical Co., Ltd.	New use of the adenosine antagonist
GB9015764D0 (en) *	1990-07-18	1990-09-05	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
GB9107513D0 (en) *	1991-04-10	1991-05-29	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof
ATE161178T1 (de) *	1992-06-10	1998-01-15	Fujisawa Pharmaceutical Co	Pyrazolpyridine für die behandlung der anämie
DE69426620T2 (de) *	1993-09-06	2001-06-21	Kyowa Hakko Kogyo Kk	Antidepressiva
KR100386542B1 (ko) *	1993-12-29	2003-10-11	후지사와 야꾸힝 고교 가부시키가이샤	피라졸로피리딘아데노신길항제
US5646156A (en) *	1994-04-25	1997-07-08	Merck & Co., Inc.	Inhibition of eosinophil activation through A3 adenosine receptor antagonism
DE69731948D1 (de) *	1996-04-25	2005-01-20	Fujisawa Pharmaceutical Co	Mittel zur vorbeugung und heilung ischämischer darmlesion und ileus
AUPO111096A0 (en) *	1996-07-18	1996-08-08	Fujisawa Pharmaceutical Co., Ltd.	New compound
AU733316B2 (en) *	1996-10-04	2001-05-10	Kyorin Pharmaceutical Co. Ltd.	Pyrazolopyridylpyridazinone derivatives and process for preparing the same
WO1998041237A1 (fr) *	1997-03-18	1998-09-24	Fujisawa Pharmaceutical Co., Ltd.	Medicaments pour la prevention et la therapie de l'hyperphosphatemie
KR100382619B1 (ko) *	1997-09-05	2003-05-09	글락소 그룹 리미티드	2,3-디아릴-피라졸로[1,5-ｂ]피리다진 유도체, 그의 제조방법 및 시클로옥시게나제 2(ｃｏｘ-2) 억제제로서의 용도
CA2333947C (en) *	1998-06-01	2010-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
WO1999067239A1 (fr) *	1998-06-22	1999-12-29	Fujisawa Pharmaceutical Co., Ltd.	Composes pyrazolopyridiniques et leur utilisation comme medicaments
AUPP672198A0 (en) *	1998-10-23	1998-11-19	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
ES2228127T3 (es)	1998-11-03	2005-04-01	Glaxo Group Limited	Derivados de pirazolopiridina como inhibidores selectivos de cox-2.
US6541634B2 (en)	1999-02-26	2003-04-01	Pfizer Inc.	Process for preparing growth hormone secretagogues
ES2216631T3 (es)	1999-02-27	2004-10-16	Glaxo Group Limited	Pirazolpiridinas.
US20040152659A1 (en) *	1999-05-12	2004-08-05	Fujisawa Pharmaceutical Co. Ltd.	Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
AUPQ441499A0 (en) *	1999-12-02	2000-01-06	Fujisawa Pharmaceutical Co., Ltd.	Novel compound
GB9930358D0 (en)	1999-12-22	2000-02-09	Glaxo Group Ltd	Process for the preparation of chemical compounds
PE20020506A1 (es) *	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
AUPQ969800A0 (en) *	2000-08-28	2000-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
AU2002239348A1 (en) *	2000-12-15	2002-06-24	Glaxo Group Limited	Pyrazolopyridine derivatives
WO2002048147A2 (en) *	2000-12-15	2002-06-20	Glaxo Group Limited	Pyrazolopyridines
ES2316546T3 (es)	2001-02-20	2009-04-16	Astrazeneca Ab	2-arilamino-pirimidinas para el tratamiento de trastornos asociados a gsk3.
AU2002248531A1 (en) *	2001-03-08	2002-09-24	Smithkline Beecham Corporation	Pyrazolopyriadine derivatives
US7034030B2 (en)	2001-03-30	2006-04-25	Smithkline Beecham Corporation	Pyralopyridines, process for their preparation and use as therapeutic compounds
JP2004525150A (ja) *	2001-03-30	2004-08-19	スミスクラインビーチャムコーポレーション	治療用化合物としてのピラゾロピリジン類の使用
ATE332301T1 (de) *	2001-04-10	2006-07-15	Smithkline Beecham Corp	Antivirale pyrazolopyridin verbindungen
US6756498B2 (en)	2001-04-27	2004-06-29	Smithkline Beecham Corporation	Process for the preparation of chemical compounds
ES2242028T3 (es) *	2001-04-27	2005-11-01	Smithkline Beecham Corporation	Derivados de pirazolo(1,5-a)piridina.
AUPR548601A0 (en) *	2001-06-06	2001-06-28	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyrazinecompound and pharmaceutical use thereof
HUP0400266A2 (hu) *	2001-06-21	2004-08-30	Smithkline Beecham Corp.	Imidazo[1,2-a]piridin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk herpeszvírus-fertőzések megelőzésére vagy kezelésére
US20040214834A1 (en) *	2001-09-07	2004-10-28	Kristjan Gudmunsson	Pyrazolo-pyridines for the treatment of herpes infections
JP2005508955A (ja) *	2001-10-05	2005-04-07	スミスクラインビーチャムコーポレーション	ヘルペスウイルス感染の治療で使用されるためのイミダゾ−ピリジン誘導体
AUPR916301A0 (en) *	2001-11-29	2001-12-20	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
AU2002357740A1 (en) *	2001-12-11	2003-06-23	Smithkline Beecham Corporation	Pyrazolo-pyridine derivatives as antiherpes agents
US20040021778A1 (en) *	2002-08-05	2004-02-05	Oldani Jerome L.	Security system with remote access and control
GB0218876D0 (en) *	2002-08-13	2002-09-25	Merck Sharp & Dohme	Therapeutic agents
WO2004033454A1 (en) *	2002-10-03	2004-04-22	Smithkline Beecham Corporation	Therapeutic compounds based on pyrazolopyridine derivatives
JP5352452B2 (ja) *	2006-06-06	2013-11-27	メディシノバ，インコーポレイテッド	置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
KR100809368B1 (ko) *	2006-08-09	2008-03-05	한국과학기술원	성대파를 이용한 음색 변환 시스템
ES2396126T3 (es)	2008-04-15	2013-02-19	Eisai R&D Management Co., Ltd.	Compuesto de 3-fenilpirazol[5,1-b]tiazol
WO2010144416A1 (en) *	2009-06-08	2010-12-16	Gaeta Federico C A	SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
WO2011043387A1 (ja) *	2009-10-08	2011-04-14	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラゾロオキサゾール化合物
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
CA2782601C (en)	2009-12-18	2015-07-21	Mitsubishi Tanabe Pharma Corporation	Novel antiplatelet agent
CN104540835B (zh)	2012-04-26	2017-08-08	百时美施贵宝公司	用于治疗血小板聚集的作为蛋白酶激活受体4(par4)抑制剂的咪唑并噻二唑衍生物
ES2617879T3 (es)	2012-04-26	2017-06-20	Bristol-Myers Squibb Company	Derivados de imidazotiadiazol e imidazopiridazina como inhibidores del receptor activado por proteasa 4 (PAR4) para el tratamiento de la agregación plaquetaria
SG11201406757SA (en)	2012-04-26	2014-11-27	Bristol Myers Squibb Co	Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US9572528B1 (en)	2012-08-06	2017-02-21	Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center	Monitor for SIDS research and prevention
RU2670978C9 (ru) *	2013-05-28	2018-11-22	Раквалиа Фарма Инк.	Полиморфные формы
US9598419B1 (en)	2014-06-24	2017-03-21	Universite De Montreal	Imidazotriazine and imidazodiazine compounds
US9617279B1 (en)	2014-06-24	2017-04-11	Bristol-Myers Squibb Company	Imidazooxadiazole compounds
CN106459147B (zh) *	2014-08-05	2021-08-06	拉夸里亚创药株式会社	作为生长激素释放肽受体激动剂的丝氨酸衍生物
SG11202109568TA (en) *	2019-03-20	2021-10-28	Goldfinch Bio Inc	Pyridazinones and methods of use thereof
KR20220043919A (ko) *	2020-09-29	2022-04-05	연세대학교 산학협력단	호흡기 질환의 예방 또는 치료용 조성물 및 예방 또는 치료 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5154583A (en) *	1974-11-01	1976-05-13	Kyorin Seiyaku Kk	Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
AU556031B2 (en) *	1982-06-16	1986-10-16	May And Baker Ltd.	3-(n,n-dimethylcarbamoyl)pyrazolo(1,5-alpha)-pyridine
FR2601368B1 (fr) *	1986-07-08	1989-04-07	Synthelabo	Derives de nitrofuranne, leur preparation et leur application en therapeutique.
JPS63135381A (ja) *	1986-11-26	1988-06-07	Kyorin Pharmaceut Co Ltd	多剤耐性癌細胞に対する感受性増強剤及びその製造方法
DE3710937A1 (de) *	1987-04-01	1988-10-13	Boehringer Mannheim Gmbh	Chromogene verbindungen, ihre herstellung und verwendung als enzymsubstrate
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines

1989
- 1989-01-23 GB GB898901423A patent/GB8901423D0/en active Pending
1990
- 1990-01-09 PH PH39909A patent/PH30968A/en unknown
- 1990-01-11 ZA ZA90200A patent/ZA90200B/xx unknown
- 1990-01-14 IL IL9305090A patent/IL93050A/en not_active IP Right Cessation
- 1990-01-15 IE IE900161A patent/IE900161L/xx not_active Application Discontinuation
- 1990-01-18 US US07/466,929 patent/US4985444A/en not_active Expired - Lifetime
- 1990-01-19 DE DE69030206T patent/DE69030206T2/de not_active Expired - Fee Related
- 1990-01-19 AT AT90101042T patent/ATE150462T1/de not_active IP Right Cessation
- 1990-01-19 DK DK90101042.1T patent/DK0379979T3/da active
- 1990-01-19 EP EP90101042A patent/EP0379979B1/de not_active Expired - Lifetime
- 1990-01-19 ES ES90101042T patent/ES2098229T3/es not_active Expired - Lifetime
- 1990-01-19 FI FI900307A patent/FI96205C/fi not_active IP Right Cessation
- 1990-01-22 CA CA002008263A patent/CA2008263C/en not_active Expired - Fee Related
- 1990-01-22 RU SU904742944A patent/RU2007403C1/ru not_active IP Right Cessation
- 1990-01-22 JP JP2012995A patent/JPH0794454B2/ja not_active Expired - Fee Related
- 1990-01-22 KR KR1019900000690A patent/KR0159502B1/ko not_active IP Right Cessation
- 1990-01-22 HU HU90228A patent/HUT53368A/hu unknown
- 1990-01-22 NO NO900306A patent/NO176356C/no not_active IP Right Cessation
- 1990-01-23 AU AU48696/90A patent/AU628913B2/en not_active Ceased
- 1990-01-23 PT PT92935A patent/PT92935B/pt not_active IP Right Cessation
- 1990-01-23 CN CN90100900A patent/CN1031570C/zh not_active Expired - Fee Related
1993
- 1993-06-18 UA UA93002311A patent/UA43821C2/uk unknown
1995
- 1995-03-23 JP JP7064422A patent/JPH0881465A/ja active Pending
- 1995-06-22 HU HU95P/P00351P patent/HU211684A9/hu unknown
1997
- 1997-04-22 GR GR970400879T patent/GR3023219T3/el unknown

Also Published As

Publication number	Publication date
NO176356B (no)	1994-12-12
CN1031570C (zh)	1996-04-17
JPH0881465A (ja)	1996-03-26
AU628913B2 (en)	1992-09-24
IL93050A (en)	1995-05-26
NO176356C (no)	1995-03-22
KR900011773A (ko)	1990-08-01
HUT53368A (en)	1990-10-28
ES2098229T3 (es)	1997-05-01
FI900307A0 (fi)	1990-01-19
RU2007403C1 (ru)	1994-02-15
FI96205C (fi)	1996-05-27
EP0379979A1 (de)	1990-08-01
DE69030206T2 (de)	1997-07-10
DE69030206D1 (de)	1997-04-24
ZA90200B (en)	1990-10-31
CA2008263A1 (en)	1990-07-23
DK0379979T3 (de)	1997-04-07
PH30968A (en)	1997-12-23
HU211684A9 (en)	1995-12-28
AU4869690A (en)	1990-07-26
UA43821C2 (uk)	2002-01-15
IE900161L (en)	1990-07-23
GR3023219T3 (en)	1997-07-30
CA2008263C (en)	2000-03-14
KR0159502B1 (ko)	1998-12-01
JPH0794454B2 (ja)	1995-10-11
HU900228D0 (en)	1990-03-28
NO900306D0 (no)	1990-01-22
CN1044656A (zh)	1990-08-15
IL93050A0 (en)	1990-11-05
PT92935B (pt)	1995-12-29
US4985444A (en)	1991-01-15
EP0379979B1 (de)	1997-03-19
NO900306L (no)	1990-07-24
JPH02243689A (ja)	1990-09-27
GB8901423D0 (en)	1989-03-15
PT92935A (pt)	1990-07-31
FI96205B (fi)	1996-02-15

Legal Events

Date	Code	Title	Description
1997-09-15	UEP	Publication of translation of european patent specification
2004-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE150462T1 (de)	1997-04-15	Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
ATE172731T1 (de)	1998-11-15	Pyrazolopyridinverbindung und verfahren zu ihrer herstellung
ATE127801T1 (de)	1995-09-15	Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
ATE133667T1 (de)	1996-02-15	Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE146473T1 (de)	1997-01-15	Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
DE68929368D1 (de)	2002-02-21	Cephemderivate und Verfahren zu ihrer Herstellung
ATE48001T1 (de)	1989-12-15	Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
ATE141606T1 (de)	1996-09-15	Cephemverbindungen und verfahren zu ihrer herstellung
DE3868013D1 (de)	1992-03-05	Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE41659T1 (de)	1989-04-15	Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE146476T1 (de)	1997-01-15	Cephalosporinverbindungen und verfahren zu ihrer herstellung
ATE131480T1 (de)	1995-12-15	Pyrimidoindolderivate und verfahren zu ihrer herstellung
DE3772852D1 (de)	1991-10-17	Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE97902T1 (de)	1993-12-15	Cephemverbindungen und verfahren zu ihrer herstellung.
IT1229846B (it)	1991-09-13	Esteri di catecolammine.